(Q47659660)

English

Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Harlan M. Krumholz

15

object named as

Harlan M Krumholz

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

14

object named as

Khurram Nasir

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

Frederick Masoudi

8

object named as

Frederick A Masoudi

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

16

object named as

Lixin Jiang

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

3

object named as

Xueke Bai

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Elias Mossialos

6

object named as

Elias Mossialos

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

author name string

Meng Su

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Qiuli Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Chaoqun Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Yetong Li

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

George A Mensah

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Jiapeng Lu

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Xi Li

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Sebastian Salas-Vega

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Anwen Zhang

12

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Yuan Lu

13

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

language of work or name

0 references

publication date

25 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

390

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

10112

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

2559-2568

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chinese Hypertension Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of China's national essential medicines policy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of hypertension in China: A nationally representative survey of 174,621 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, Awareness, Treatment, Control and Risk Factors Associated with Hypertension among Adults in Southern China, 2013

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension burden and control in mainland China: Analysis of nationwide data 2003-2012.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of chronic non-communicable diseases in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of China's national essential medicine system on improving rational drug use in primary health care facilities: an empirical study in four provinces

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Launch of the health-care reform plan in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the effects of comprehensive reform on primary healthcare institutions in Anhui Province

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protocol for a nationwide survey of primary health care in China: the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) MPP (Million Persons Project) Primary Health Care Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

National trends in patient safety for four common conditions, 2005-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Organizational barriers associated with the implementation of national essential medicines policy: A cross-sectional study of township hospitals in China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prescribing pattern of antihypertensive drugs in a general hospital in central China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential medicine policy in China: pros and cons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Early appraisal of China's huge and complex health-care reforms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A strategy for health care reform--toward a value-based system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The high price of anticancer drugs: origins, implications, barriers, solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2932476-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)32476-5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/29102087

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47659660&oldid=2164374697"